abstract |
The present invention provides a therapeutically or prophylactically effective amount of a COX-2 selective inhibitor and a cardiovascular protective amount for treating or preventing a COX-2-mediated condition in a patient at risk of developing a thromboembolic event. And administering to the patient a thromboxane inhibitor of the present invention. |